Even a combination of the best available biomarkers is only about 70 percent accurate in predicting cognitive decline, making them ineffective for clinical use. Scientists are actively developing next-generation biomarkers like eMTBR-tau243 to track tau tangles and which may be better at predicting cognitive decline.
